Among adults invited for colorectal cancer #FIT screening, adding H pylori stool antigen testing improved lifetime health outcomes and was cost-effective or cost-saving in most scenariosโeven with incomplete adherenceโwhen H pylori prevalence was moderate.
https://t.co/7vuLnp0S74
A practical roadmap for MASH care: start with two-step noninvasive risk stratification, lifestyle intervention throughout, and reserve liver-targeted therapy for patients with F2โF3 fibrosis and no cirrhosis.
https://t.co/cCM7B8Uz7A
๐ก JAMA Insights: #GLP1 receptor agonists and dual incretin agents support weight loss with minimal lifestyle counseling, but diet and activity advice remain necessary for safety and long-term success in #Obesity care.
https://t.co/pFK8LgavVl